Lefebvre R A, Rosseel M T, Bernheim J
Heymans Institute of Pharmacology, University of Gent Medical School, Belgium.
Int J Clin Pharmacol Res. 1988;8(6):463-70.
The pharmacokinetics of the H1-receptor antagonist cetirizine were studied from 0 to 48 h after a single oral intake of 10 mg in 10 elderly volunteers (60 to 90 years) and in 10 young healthy volunteers (21 to 29 years). In young healthy volunteers about 60% of an oral dose of cetirizine was excreted in the urine in unchanged form. Mean plasma concentrations were slightly higher in the elderly subjects. Cmax (362 ng/ml), Tmax (1.30 h), terminal half-life (11.8 h) and AUC infinity (4316 ng.h/ml) in the elderly subjects were somewhat higher than in the young subjects (Cmax: 337 ng/ml, Tmax: 1.12 h, terminal half-life: 10.6 h, AUC: 3721 ng.h/ml), but the difference was not significant. The mean cumulative urinary excretion at 32 h was significantly lower in the elderly subjects. It is concluded that the slight differences in pharmacokinetics of cetirizine between young and elderly subjects after single oral intake can be attributed to the decreased renal clearance in the elderly.
在10名老年志愿者(60至90岁)和10名年轻健康志愿者(21至29岁)单次口服10毫克西替利嗪后,研究了0至48小时内H1受体拮抗剂西替利嗪的药代动力学。在年轻健康志愿者中,口服剂量的西替利嗪约60%以原形经尿液排出。老年受试者的平均血浆浓度略高。老年受试者的Cmax(362纳克/毫升)、Tmax(1.30小时)、终末半衰期(11.8小时)和AUC∞(4316纳克·小时/毫升)略高于年轻受试者(Cmax:337纳克/毫升,Tmax:1.12小时,终末半衰期:10.6小时,AUC:3721纳克·小时/毫升),但差异不显著。老年受试者在32小时时的平均累积尿排泄量显著较低。结论是,单次口服后年轻与老年受试者之间西替利嗪药代动力学的细微差异可归因于老年人肾清除率降低。